FNY Investment Advisers’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $208K | Buy |
7,884
+1,834
| +30% | +$48.4K | 0.09% | 205 |
|
|
2025
Q1 | $146K | Sell |
6,050
-100
| -2% | -$2.41K | 0.09% | 174 |
|
|
2024
Q4 | $247K | Sell |
6,150
-5,825
| -49% | -$234K | 0.13% | 157 |
|
|
2024
Q3 | $758K | Buy |
11,975
+5,338
| +80% | +$338K | 0.37% | 76 |
|
|
2024
Q2 | $351K | Buy |
6,637
+1,387
| +26% | +$73.4K | 0.24% | 73 |
|
|
2024
Q1 | $430 | Buy |
+5,250
| New | +$430 | 0.26% | 77 |
|
|
2023
Q1 | – | Sell |
-40
| Closed | – | – | 740 |
|
|
2022
Q4 | $0 | Sell |
40
-140
| -78% | – | ﹤0.01% | 752 |
|
|
2022
Q3 | $0 | Hold |
180
| – | – | ﹤0.01% | 844 |
|
|
2022
Q2 | $0 | Hold |
180
| – | – | ﹤0.01% | 899 |
|
|
2022
Q1 | $0 | Hold |
180
| – | – | ﹤0.01% | 880 |
|
|
2021
Q4 | $0 | Hold |
180
| – | – | ﹤0.01% | 775 |
|
|
2021
Q3 | $1K | Hold |
180
| – | – | ﹤0.01% | 607 |
|
|
2021
Q2 | $1K | Hold |
180
| – | – | ﹤0.01% | 657 |
|
|
2021
Q1 | $1K | Sell |
180
-40
| -18% | -$222 | ﹤0.01% | 680 |
|
|
2020
Q4 | $1K | Hold |
220
| – | – | ﹤0.01% | 667 |
|
|
2020
Q3 | $1K | Hold |
220
| – | – | ﹤0.01% | 412 |
|
|
2020
Q2 | $1K | Hold |
220
| – | – | ﹤0.01% | 344 |
|
|
2020
Q1 | $1K | Hold |
220
| – | – | ﹤0.01% | 369 |
|
|
2019
Q4 | $1K | Sell |
220
-5,000
| -96% | -$22.7K | ﹤0.01% | 701 |
|
|
2019
Q3 | $35K | Hold |
5,220
| – | – | 0.01% | 435 |
|
|
2019
Q2 | $43K | Sell |
5,220
-80
| -2% | -$659 | 0.01% | 381 |
|
|
2019
Q1 | $52K | Buy |
5,300
+300
| +6% | +$2.94K | 0.02% | 322 |
|
|
2018
Q4 | $38K | Sell |
5,000
-14,500
| -74% | -$110K | 0.01% | 268 |
|
|
2018
Q3 | $339K | Buy |
19,500
+13,500
| +225% | +$235K | 0.08% | 142 |
|
|
2018
Q2 | $56K | Buy |
+6,000
| New | +$56K | 0.02% | 262 |
|